Rezolute (RZLT) Competitors $4.78 -0.09 (-1.75%) Closing price 07/3/2025 03:04 PM EasternExtended Trading$4.78 0.00 (0.00%) As of 07/3/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RZLT vs. JANX, EVO, MESO, VERA, OCUL, TVTX, BGM, GPCR, CVAC, and CALTShould you be buying Rezolute stock or one of its competitors? The main competitors of Rezolute include Janux Therapeutics (JANX), Evotec (EVO), Mesoblast (MESO), Vera Therapeutics (VERA), Ocular Therapeutix (OCUL), Travere Therapeutics (TVTX), BGM Group (BGM), Structure Therapeutics (GPCR), CureVac (CVAC), and Calliditas Therapeutics AB (publ) (CALT). These companies are all part of the "pharmaceutical products" industry. Rezolute vs. Its Competitors Janux Therapeutics Evotec Mesoblast Vera Therapeutics Ocular Therapeutix Travere Therapeutics BGM Group Structure Therapeutics CureVac Calliditas Therapeutics AB (publ) Rezolute (NASDAQ:RZLT) and Janux Therapeutics (NASDAQ:JANX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment. Which has more volatility & risk, RZLT or JANX? Rezolute has a beta of 1.03, suggesting that its share price is 3% more volatile than the S&P 500. Comparatively, Janux Therapeutics has a beta of 2.86, suggesting that its share price is 186% more volatile than the S&P 500. Do institutionals and insiders have more ownership in RZLT or JANX? 83.0% of Rezolute shares are owned by institutional investors. Comparatively, 75.4% of Janux Therapeutics shares are owned by institutional investors. 18.4% of Rezolute shares are owned by company insiders. Comparatively, 8.1% of Janux Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has higher earnings and valuation, RZLT or JANX? Rezolute has higher earnings, but lower revenue than Janux Therapeutics. Janux Therapeutics is trading at a lower price-to-earnings ratio than Rezolute, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRezoluteN/AN/A-$68.46M-$1.15-4.15Janux Therapeutics$10.59M137.11-$68.99M-$1.36-18.04 Does the media refer more to RZLT or JANX? In the previous week, Rezolute's average media sentiment score of 0.00 equaled Janux Therapeutics'average media sentiment score. Company Overall Sentiment Rezolute Neutral Janux Therapeutics Neutral Do analysts rate RZLT or JANX? Rezolute presently has a consensus price target of $11.83, indicating a potential upside of 147.82%. Janux Therapeutics has a consensus price target of $95.25, indicating a potential upside of 288.14%. Given Janux Therapeutics' higher possible upside, analysts plainly believe Janux Therapeutics is more favorable than Rezolute.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rezolute 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14Janux Therapeutics 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 3.09 Is RZLT or JANX more profitable? Janux Therapeutics' return on equity of -9.29% beat Rezolute's return on equity.Company Net Margins Return on Equity Return on Assets RezoluteN/A -70.09% -63.08% Janux Therapeutics N/A -9.29%-8.89% SummaryJanux Therapeutics beats Rezolute on 7 of the 13 factors compared between the two stocks. Get Rezolute News Delivered to You Automatically Sign up to receive the latest news and ratings for RZLT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RZLT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RZLT vs. The Competition Export to ExcelMetricRezoluteMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$412.20M$2.89B$5.56B$9.04BDividend YieldN/A2.44%5.24%4.01%P/E Ratio-4.1521.7127.6620.25Price / SalesN/A281.81415.41118.18Price / CashN/A42.7336.8958.07Price / Book2.187.518.035.67Net Income-$68.46M-$55.14M$3.18B$249.21M7 Day Performance9.77%4.61%2.93%3.27%1 Month Performance10.79%4.72%3.75%5.55%1 Year Performance15.62%5.92%35.20%21.08% Rezolute Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RZLTRezolute2.2667 of 5 stars$4.78-1.7%$11.83+147.8%+14.5%$412.20MN/A-4.1540JANXJanux Therapeutics1.4517 of 5 stars$22.88-3.1%$95.25+316.3%-36.3%$1.40B$10.59M-16.8230EVOEvotec1.7188 of 5 stars$3.81+1.3%$5.93+55.7%-18.5%$1.34B$862.40M0.004,827News CoverageGap UpMESOMesoblast2.3792 of 5 stars$10.16-2.7%$18.00+77.2%+58.6%$1.33B$5.90M0.0080Positive NewsVERAVera Therapeutics3.511 of 5 stars$21.65+3.8%$65.00+200.2%-31.9%$1.33BN/A-7.2240OCULOcular Therapeutix3.9657 of 5 stars$8.37+3.0%$17.33+107.1%+39.9%$1.30B$63.72M-7.28230Gap UpTVTXTravere Therapeutics3.1867 of 5 stars$14.49+1.3%$32.14+121.8%+88.9%$1.27B$233.18M-5.16460Analyst ForecastAnalyst RevisionBGMBGM GroupN/A$13.12+0.4%N/AN/A$1.27B$25.10M0.00298High Trading VolumeGPCRStructure Therapeutics2.9243 of 5 stars$22.10+1.7%$76.17+244.6%-44.9%$1.25BN/A-25.40136Positive NewsHigh Trading VolumeCVACCureVac4.6413 of 5 stars$5.39-0.9%$9.00+67.0%+72.9%$1.22B$579.18M5.86880CALTCalliditas Therapeutics AB (publ)N/A$40.00flatN/AN/A$1.19B$1.60B-21.62180 Related Companies and Tools Related Companies JANX Alternatives EVO Alternatives MESO Alternatives VERA Alternatives OCUL Alternatives TVTX Alternatives BGM Alternatives GPCR Alternatives CVAC Alternatives CALT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RZLT) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rezolute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rezolute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RZLT Stock Alerts